Clinical Trials Logo

Clinical Trial Summary

A multicenter study to evaluate the safety and efficacy of Zylet compared to vehicle in children aged 0-6 for the management of lid inflammation (chalazion/hordeolum)


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00420628
Study type Interventional
Source Bausch & Lomb Incorporated
Contact
Status Completed
Phase Phase 4
Start date November 2006
Completion date June 2009

See also
  Status Clinical Trial Phase
Completed NCT01202747 - Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction Phase 2/Phase 3
Completed NCT02338648 - Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion Phase 2
Withdrawn NCT01763437 - Intralesional Tetracycline Injection in the Treatment of Chalazia Phase 0
Completed NCT03248440 - Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion Phase 3
Recruiting NCT05070611 - Efficacy of Intense Pulsed Light in the Treatment of Recurrent Chalazia N/A
Completed NCT00832130 - Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye N/A
Completed NCT04322500 - Probiotics for Chalaziosis Treatment in Children N/A
Completed NCT04342507 - Probiotics for Treatment of Chalazion in Adults N/A
Recruiting NCT02025023 - Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study Phase 3
Recruiting NCT05512572 - Therapeutic Efficacy of Intense Pulsed Light in the Treatment of Chalazion N/A